Skip to main content
. 2021 Jul 20;2021(7):CD013196. doi: 10.1002/14651858.CD013196.pub2

NCT01512992.

Methods Study design: unknown centres, single‐blinded, parallel individual randomised controlled trial in Spain
Duration: 12 weeks
Setting: clinic, hospital
Participants Population: 380 adults recruited from clinics/hospitals in Spain
Baseline characteristics: unknown
Inclusion criteria: ≥ 40 years of age, COPD exacerbation, willing to participate in study, able to use devices for study
Exclusion criteria: participated in previous COPD home telehealth study
Interventions Measurements taken at baseline and at 3 months
Treatment arms
  1. Remote monitoring for low‐complexity patients and videoconferencing remote monitoring for high‐complexity patients

  2. Personalised care plan

  3. Self‐management education for disease

Outcomes Primary outcomes: hospital re‐admissions
Secondary outcomes: HQOL by SF‐36, FEV₁, CAT, HADS, mortality, time to first re‐admission, emergency department visits, length of stay for re‐admission, patient satisfaction
Notes Funding: Catalan Agency for Health Information, Assessment, and Quality
Other identifier:NCT01512992